Connect with us

Technology

Sisram Medical Announces 2024 Annual Results

Published

on

New product launches drive double-digit growth in key markets and deliver market outperformance amid economic challenges 

HONG KONG, March 19, 2025 /PRNewswire/ — Sisram Medical Ltd (the “Company” or “Sisram”, 1696.HK; together with its subsidiaries collectively referred to as the “Group”), a global consumer wellness group, featuring a distinguished synergistic ecosystem of business building blocks and consumer-focused approaches including Energy-Based Devices (EBD), Injectables, alongside other complementary offerings,  announced its audited consolidated annual results for the year ended December 31, 2024 (the “Reporting Period”).

FINANCIAL HIGHLIGHTS

Revenue was US$349.1 million, representing a decrease of 2.8% YoY.Gross profit margin was 62.1%, representing an increase of 1.0 percentage point from 61.1% in 2023.Revenue portion derived from direct sales for the year ended December 31, 2024, was 87% of total revenue, as compared to 78% for the corresponding period in 2023. Revenues in Asia Pacific, European, Middle East and Africa were US$116.2 million, US$50.5 million, US$34.6 million, increased by 6.0%, 0.7%, and 27.1%, respectively. Revenue in North America was US$137.4 million, representing a decrease of 12.4% YoY.Net profit was US$28.8 million, representing a decrease of 12.6% YoY.

FINAL DIVIDEND

The Board has resolved to declare a final dividend of HK$0.126 (inclusive of tax) per share for the year ended December 31, 2024.

KEY ACHIEVEMENTS

Confidence in Sisram’s Core Platform Reaches an All-Time High reflected by remarkable market adoption of new products:

Alma Harmony™: An innovative, cutting-edge, multi-modal anti-aging platform designed to address multiple signs of aging across all skin types and diverse demographics. Following its record-breaking performance in the U.S. (H1 2024), Alma’s new multiplatform was launched globally to unprecedented demand and better-than-expected market adoption, making it the most successful product launch in Sisram’s history. The new platform also drives growth across the entire Harmony family.

Continuing its leadership in the hair removal segment, Alma launched the Special Edition of Soprano Titanium globally, supported by cross-territorial B2B and B2C campaigns. This new and improved flagship hair removal platform delivers 20% more energy while remaining virtually painless. According to Sapio Research, an independent global research agency, the new Soprano is the fastest hair removal treatment on the market compared to leading global laser hair removal brands.

The Company’s quality management system has been successfully audited and found compliant with European MDR requirements, laying a solid foundation for the rapid launch of certified products in Europe and other CE-related countries, such as Korea, the UK, and Australia, in the future.

Advancing Integrative Solutions to Drive Profitable Growth

After several years of dedicated development, we are excited to introduce a groundbreaking diagnostic concept – Alma IQ™: A completely new intelligent skin analysis and consultation solution, offering a visually engaging, interactive, and automated experience while addressing patients’ skin health concerns. The product was introduced to the North American market with immediate adoption and will be launched globally in 2025 as a key component of Sisram’s synergetic offering, further strengthening the Company’s product portfolio and competitive advantages.

In the injectables segment, we made continued efforts to grow and optimize our commercialization infrastructure. DAXXIFY® received NMPA approval, marking it as the first Daxibotulinumtoxin A botulinum toxin to be approved in mainland China. Designed to improve moderate to severe glabellar lines, it is set for launch in 2025, contributing to the Company’s wellness ecosystem and long-term development.

Additionally, the Company entered into a partnership with Prollenium® to distribute the Revanesse® dermal filler collection in key markets. Revanesse®, which utilizes advanced hyaluronic acid technology, was successfully launched in the UK during the reporting period.

Moreover, Profhilo®, a next-generation hyaluronic acid injectable, received approval as a medical device from the Hainan Medical Products Administration in April 2024. It was also launched in Thailand, further enriching the Company’s injectables portfolio and expanding its global market presence.

In addition, as part of expanding our injectables portfolio with innovative, high-end products, Sisram has partnered with Hallura® for the exclusive distribution of their first-of-its-kind combination of HA and bio-stimulator in strategic markets.

Strengthening Direct-Sales Presence and Operational Excellence

The Company established a direct sales office in Thailand in September 2024 and has been actively driving the rapid growth of its direct sales markets worldwide. As a result, the revenue contribution from direct sales reached a record high, contributing to a 1 percentage point increase in gross profit margin during the Reporting Period. This also strengthened the Company’s market penetration and operational efficiency.

Driven by new product launches and accelerated market expansion, revenue from the North American market grew by 5.0% period-on-period in the second half of 2024, mitigating the impact of local economic conditions on customers’ order cycles.

During the reporting period, the Company accelerated the integration of its investments in the Chinese market, laying a solid foundation for future growth. By enhancing its brands and channels through multiple dimensions—including team development, product portfolio expansion, brand positioning, and business growth—the Company has strengthened its competitive edge and market presence.

Strategy and Outlook

Sisram will continue to execute our strategy by extending the Company’s global footprint, focusing on developing its direct-sales offices and supporting their growth milestones. The Company will seize opportunities from recently launched technologies, continue building the commercialization of upcoming product launches, and strengthen its high-end brand positioning. With North America and the Asia-Pacific regions as core strategic markets, the Company aims to drive sustained business growth and achieve global breakthroughs. Building on the strong momentum of its integrative solutions, Sisram will continue to drive growth through recent portfolio advancements, including Alma IQ™, its premium injectable offerings, and the highly anticipated launch of its skincare solutions in H1 2025.

To drive the rapid growth of its injectables product line, the Company will continue accelerating the launch of DAXXIFY® and streamline its commercialization process in mainland China. Sisram will also focus on promoting other injectable filler products in various markets, including Profhilo® in Thailand, Hallura® in Israel and Revanesse® in the UK to accelerate the development of the injectables line as Company’s second core growth engine.

In addition, the Company continued to build the infrastructure for its highly-anticipated innovative skin-care concept, upcoming 2025 launch. Designed to complement in-clinic treatments, personalize formulations are tailored to each patient’s unique skin profile and concerns. By integrating advanced, science-backed ingredients with a customizable approach, the new solution by Alma enhances treatment outcomes and extends the benefits of aesthetic care beyond the clinic.

Mr. Liu Yi, Chairman and Executive Director of Sisram, commented: “In 2025, our efforts will remain aligned with market needs and core strengths while enhancing the profitability of our core business. We will also focus our resources on accelerating the commercialization of key products and advancing the development of our injectables line. By combining advanced technologies with comprehensive solutions and tailored treatment experiences, we are committed to building a wellness ecosystem and elevating our products from standalone tools to integrated solutions—delivering more precise and holistic wellness experiences to consumers worldwide“.

Mr. Lior Dayan, CEO of Sisram and Alma, said: “Sisram’s growth in 2024 was driven by consistent expansion in international markets, with many of our key markets achieving double-digit growth①, fueled by the launch of our innovative new products that are redefining professional practice and patient care. Looking ahead to 2025, we are confident that our strategic approach, combined with our leadership in the EBD segment, will drive sustained growth and enable us to seize new opportunities for continued success in the years to come“.

①     Sisram delivered nearly 20% growth in the direct offices, outside North America.

About Sisram Medical Ltd

Sisram Medical Ltd (1696.HK) is a global consumer wellness group, featuring a first-of-its-kind synergistic ecosystem of business building blocks and consumer-focused branding. The Company is majority-owned by Fosun Pharma, one of China’s leading healthcare groups. Sisram Medical went public on the Main Board of the Hong Kong Exchange in September 2017.

Sisram Medical – Enhancing Quality of Life

http://www.sisram-medical.com

 

View original content:https://www.prnewswire.com/news-releases/sisram-medical-announces-2024-annual-results-302405890.html

SOURCE Sisram Medical Ltd

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Portland General Electric declares dividend

Published

on

By

PORTLAND, Ore., July 24, 2026 /PRNewswire/ — The board of directors of Portland General Electric Company (NYSE: POR) declared a quarterly common stock dividend of $0.55125 per share.

The company’s dividend is evaluated based on capital requirements and financial performance. PGE targets a dividend payout ratio of 60 to 70% over the long term.

The quarterly dividend is payable on or before October 15, 2026, to shareholders of record at the close of business on September 25, 2026.

About Portland General Electric Company
Portland General Electric (NYSE: POR) is an integrated energy company that generates, transmits and distributes electricity to nearly 960,000 customers serving an area of approximately 2 million Oregonians. Since 1889, Portland General Electric (PGE) has been powering economies, delivering safe, affordable and reliable electricity while working to transform energy systems to meet evolving customer needs. PGE continues to make progress towards emissions reduction targets, and customers have set the standard for prioritizing clean energy with the No. 1 voluntary renewable energy program in the country. PGE is ranked a top ten utility in the 2025 Forrester U.S. Customer Experience Index. In 2025, PGE employees and retirees volunteered over 18,300 hours to more than 400 nonprofits organizations. Through the PGE Foundation, along with corporate contributions and the employee matching gift program, more than $5 million was directed to charitable organizations supporting economic growth and community resilience across our service area. For information: portlandgeneral.com/news.

Safe Harbor Statement

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are based on assumptions about the future, involve risks and uncertainties, and are not guarantees. Future results may differ materially from those expressed or implied in any forward-looking statement. These forward-looking statements represent our estimates and assumptions only as of the date of this press release. We assume no obligation to update or revise any forward-looking statement as a result of new information, future events or otherwise.

Forward-looking statements include statements, other than statements of historical or current fact, regarding the Company’s amount and timing of dividends payable as well as other statements containing words such as “committed to,” “targets,” or similar expressions.

There can be no assurance that future dividends will be declared. The declaration of future dividends is subject to approval of our board of directors and various risks and uncertainties, including, but not limited to: our cash flow and cash needs; the timing or amount of dividends paid; the timing or outcome of various legal and regulatory actions; changes in the Company’s business strategy; increases in capital expenditures; changes in capital and credit market conditions, including volatility of equity markets as well as changes in PGE’s credit ratings and outlook on such credit ratings restrictions on the payment of dividends under existing or future financing arrangements; changes in tax laws relating to corporate dividends; deterioration in our financial condition or results, and those risks, uncertainties, and other factors identified from time-to-time in our filings with the United States Securities and Exchange Commission (SEC), including our annual report on Form 10-K for the year ended December 31, 2025 and subsequent quarterly reports on Form 10-Q. These reports are available through the EDGAR system free-of-charge on the SEC’s website, www.sec.gov and on the Company’s website, investors.portlandgeneral.com. Investors should not rely unduly on any forward-looking statements. The Company assumes no obligation to update or revise any forward-looking statement as a result of new information, future events or other factors.

Media Contact:
Drew Hanson
Corporate Communications
Phone: 503-464-2067

Investor Contact:
Erin Schwartz
Investor Relations
Phone: 503-464-7751

View original content:https://www.prnewswire.com/news-releases/portland-general-electric-declares-dividend-302834503.html

SOURCE Portland General Company

Continue Reading

Technology

Care Career Announces Acquisition of MAS Medical Staffing, Completing Its First Acquisition Phase and Expanding Annual Revenue Beyond $150 Million, with a Path to Exceed a Quarter Billion by the End of 2026 Through Additional Acquisitions and Organic Growth

Published

on

By

WOODBRIDGE, N.J., July 24, 2026 /PRNewswire/ — Care Career, a rapidly growing healthcare workforce technology organization, today announced the acquisition of MAS Medical Staffing, one of the Northeast’s leading healthcare workforce organizations. Financial terms of the transaction were not disclosed.

The acquisition represents Care Career’s seventh strategic acquisition in the past 24 months, further strengthening the company’s position as one of the largest healthcare workforce organizations in the United States while accelerating its strategy to redefine the future of healthcare workforce management through artificial intelligence, enterprise technology, and workforce innovation.

MAS Medical Staffing has built an outstanding reputation for delivering high-quality workforce solutions through strong client relationships, exceptional clinician engagement, and deep regional expertise throughout the Northeastern United States. The acquisition significantly expands Care Career’s geographic footprint while broadening its access to healthcare professionals, client relationships, workforce data, and regional market intelligence.

Care Career is building a technology-enabled workforce ecosystem powered by its AI-powered workforce platform, where every acquisition contributes not only additional market presence, but also expanded data, enhanced artificial intelligence capabilities, digital innovation, and operational scale that continuously improve the experience for clients and clinicians alike. As the platform grows, every clinician engagement, client interaction, credential, placement, and workforce trend strengthens the intelligence of Career’s technology, creating a continuously improving ecosystem designed to deliver faster, smarter, and more effective workforce solutions.

The acquisition also brings MAS Medical Staffing’s MAESTRA® engagement technology, along with its client relationships and clinician network, directly onto Career’s AI-powered workforce platform. MAESTRA’s scheduling, credentialing, and communication capabilities will be integrated into Care Career’s existing technology stack, further enhancing clinician engagement across onboarding, scheduling, and career management while providing healthcare organizations with greater workforce visibility and operational efficiency.

“Our vision is to build the AI-powered infrastructure that modernizes healthcare workforce management,” said Siva Konatham, Group President and Chief Executive Officer of Care Career. “Under my leadership, Care Career is focused on transforming a fragmented, labor-intensive industry into a data-driven, technology-enabled ecosystem that improves speed, efficiency, and workforce visibility for healthcare providers. Each acquisition strengthens our platform intelligence, expands our scale, and enhances our margin potential. By integrating advanced analytics, AI automation, and digital engagement tools, we are not just growing revenue—we are building a smarter, more scalable model positioned to lead the next era of healthcare workforce solutions.”

The combined organization will leverage expanded recruiting resources, centralized credentialing, advanced workforce analytics, AI-enabled automation, and digital engagement technologies—all powered by Care Career’s AI-powered workforce platform—to deliver broader recruiting capabilities, faster response times, enhanced workforce insights, and expanded national coverage. Clinicians will benefit from a seamless digital experience that simplifies every stage of their careers—from job discovery and credentialing to onboarding, scheduling, communication, and long-term career development.

With seven strategic acquisitions completed in less than two years, representing the first round of acquisitions now totaling more than $150 million in annual revenue, Care Career has rapidly expanded its national presence while executing a disciplined growth strategy focused on technology integration, operational excellence, and workforce innovation. The company has also signed additional Letters of Intent with other entities with expected close dates in the third quarter of 2026. Upon completion of these transactions, coupled with organic growth, Care Career expects consolidated annual revenue to exceed a quarter of a billion dollars by the end of 2026.

The addition of MAS Medical Staffing further strengthens the organization’s ability to serve healthcare systems, hospitals, long-term care providers, outpatient facilities, and other healthcare organizations across an increasingly diverse geographic footprint.

“The healthcare workforce industry is entering a new era where technology, artificial intelligence, and data-driven decision-making will define the market leaders,” Konatham added. “Every acquisition we complete expands the intelligence of our AI-powered workforce platform, enhances the value we deliver to our clients, and creates more opportunities for clinicians. We believe the combination of exceptional people, innovative technology, and strategic scale positions Care Career to lead the next generation of healthcare workforce solutions.”

About Care Career

Care Career is a technology-enabled healthcare workforce solutions company dedicated to transforming how healthcare organizations recruit, engage, credential, deploy, and retain clinical talent. Powered by its proprietary AI-powered workforce platform and supported by advanced artificial intelligence, enterprise technology, and workforce analytics, Care Career is building an intelligent healthcare workforce ecosystem that connects providers and clinicians more efficiently while improving workforce performance, operational effectiveness, and patient care. Following seven strategic acquisitions over the past 24 months the first round of acquisitions totaling more than $150 million in annual revenue and with additional signed LOIs under contract expected to complete shortly, positioning the company to surpass a quarter of a billion dollars in consolidated annual revenue by the end of 2026, Care Career has become one of the nation’s largest and fastest-growing healthcare workforce organizations, serving healthcare providers and clinicians across the United States.

About MAS Medical Staffing

MAS Medical Staffing is a premier healthcare workforce organization recognized for exceptional service, strong client partnerships, and a commitment to connecting healthcare professionals with rewarding career opportunities. With an established presence throughout the Northeastern United States, MAS Medical Staffing has earned a reputation for quality, responsiveness, and delivering workforce solutions that help healthcare providers meet their evolving workforce needs while supporting clinicians throughout every stage of their careers.

View original content to download multimedia:https://www.prnewswire.com/news-releases/care-career-announces-acquisition-of-mas-medical-staffing-completing-its-first-acquisition-phase-and-expanding-annual-revenue-beyond-150-million-with-a-path-to-exceed-a-quarter-billion-by-the-end-of-2026-through-additional-acqu-302834472.html

SOURCE Care Career

Continue Reading

Technology

PointsKash Demonstrates How Businesses Can Build on Bitcoin Without Burdening the Blockchain

Published

on

By

As industry debate surrounding Bitcoin Improvement Proposal (BIP-110) intensifies, PointsKash unveils an architecture designed to work regardless of the proposal’s outcome.

SCOTTSDALE, Ariz., July 24, 2026 /PRNewswire/ — As the global Bitcoin community debates Bitcoin Improvement Proposal 110 (BIP-110) and the future of data stored on the Bitcoin blockchain, PointsKash, Inc. today announced that its next-generation kiosk infrastructure was intentionally designed to operate efficiently under any outcome of the proposal.

Rather than storing operational data directly on the Bitcoin blockchain, PointsKash utilizes a layered architecture that combines Bitcoin‘s unmatched security with modern decentralized communications technology. Every transaction, machine event, system update, and operational record generated across the PointsKash network is cryptographically verified, securely maintained off-chain, and anchored to the Bitcoin blockchain through a single immutable cryptographic proof.

This approach allows thousands of operational events to be permanently verified while utilizing only a minimal amount of blockchain data.

As discussion surrounding BIP-110 has intensified across the digital asset industry, PointsKash believes the debate does not require choosing between innovation and responsible blockchain stewardship.

“The industry has been debating whether businesses can build meaningful applications on Bitcoin without unnecessarily consuming blockchain space,” said Michael Herron, Chief Executive Officer of PointsKash. “We believe we’ve demonstrated that the answer is yes. Bitcoin provides the world’s most trusted immutable timestamp and security layer, while higher-volume operational data belongs on technologies specifically designed to manage it. By combining both, we’ve built an architecture that is scalable, transparent, and future-ready regardless of how the BIP-110 discussion ultimately evolves.”

The company’s infrastructure assigns every kiosk its own unique cryptographic identity, allowing each machine to securely authenticate every transaction and operational event. Those records are then independently verifiable through cryptographic proofs while remaining resistant to alteration or manipulation—even by PointsKash itself.

According to the company, this architecture delivers several significant advantages:

Mathematically verifiable transaction records for regulators, banking partners, auditors, and enterprise customers.Improved network reliability, allowing kiosks to continue operating during temporary connectivity interruptions without losing transaction history.Enhanced cybersecurity, with every machine maintaining its own authenticated identity and secure communications.A scalable blockchain architecture that minimizes on-chain data while preserving complete auditability.

Bitcoin was created to provide trust, security, and permanence—not to become a storage system for every piece of application data,” Herron added. “Our philosophy has always been simple: use Bitcoin for what it does better than anyone else—creating immutable proof that records have never been altered—and leverage modern decentralized technologies for everything else. We believe that’s the future of enterprise blockchain infrastructure.”

PointsKash believes this architecture positions the company among a new generation of fintech innovators utilizing Bitcoin as a secure trust layer while developing scalable financial applications for enterprise deployment.

The technology also establishes the foundation for future blockchain-based financial products currently under development, including enhanced digital audit capabilities, verifiable financial records, enterprise licensing opportunities, and next-generation digital asset infrastructure.

As the Bitcoin ecosystem continues to mature, PointsKash believes its technology demonstrates that responsible innovation and blockchain scalability can successfully coexist—providing enterprise organizations with the confidence to build on Bitcoin without contributing unnecessary data to the network.

About PointsKash, Inc.

PointsKash, Inc. is a financial technology company developing an integrated ecosystem of AI-enabled self-service financial centers, digital banking, digital payment solutions, cryptocurrency services, loyalty rewards, enterprise merchant technologies, and mobile financial applications. Through proprietary software, Artificial Intelligence, and strategic partnerships, PointsKash is building innovative financial solutions designed to empower consumers, merchants, and enterprise organizations throughout North America.

For more information, visit www.pointskash.com.

Media Contact

PointsKash, Inc.
Investor Relations
info@pointskash.com
www.pointskash.com

Forward-Looking Statements

This press release contains forward-looking statements regarding anticipated technology integrations, Artificial Intelligence initiatives, product development, future commercialization plans, expected operational efficiencies, business strategy, and future growth. These statements are based on current expectations and involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied. Factors that could affect actual results include, but are not limited to, technology development timelines, integration efforts, financing, regulatory developments, market conditions, and other risks facing the Company. PointsKash undertakes no obligation to update any forward-looking statements except as required by applicable law.

View original content to download multimedia:https://www.prnewswire.com/news-releases/pointskash-demonstrates-how-businesses-can-build-on-bitcoin-without-burdening-the-blockchain-302834473.html

SOURCE PointsKash Inc.

Continue Reading

Trending